18th Dec 2006 12:00
Skyepharma PLC18 December 2006 For Immediate Release 18 December 2006 SkyePharma PLC - Voting Rights and Capital In conformity with the Transparency Directive's transitional provision 6 wehereby notify the market of the following: As at 18 December 2006, SkyePharma PLC's issued share capital consists of753,764,146 Ordinary Shares with voting rights. No shares are held in treasury.Therefore, the total number of voting rights in the Company is 753,764,146. The above figure (753,764,146) may be used by shareholders as the denominatorfor the calculations by which they can determine if they are required to notifytheir interest in, or a change in their interest in, SkyePharma PLC under theFSA's Disclosure and Transparency Rules. For further information please contact: SkyePharma PLC +44 207 491 1777 Frank Condella, Chief Executive OfficerKen Cunningham, Chief Operating Officer Buchanan Communications +44 207 466 5000 Tim Anderson / Mark Court / Rebecca Skye Dietrich This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
SKP.L